The India Biosimilar Market is gaining significant traction as healthcare providers, policymakers, and patients increasingly seek cost-effective alternatives to expensive biologic drugs. Biosimilars, which are highly similar to approved biologic medicines, offer comparable safety, efficacy, and quality at a lower cost. In India, the growing burden of chronic diseases, supportive regulatory...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek